BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han M, Dai D, Yousafzai NA, Wang F, Wang H, Zhou Q, Lu H, Xu W, Feng L, Jin H, Wang X. CXXC4 activates apoptosis through up-regulating GDF15 in gastric cancer. Oncotarget 2017;8:103557-67. [PMID: 29262584 DOI: 10.18632/oncotarget.21581] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Onodera A, Kiuchi M, Kokubo K, Nakayama T. Epigenetic regulation of inflammation by CxxC domain-containing proteins. Immunol Rev 2021. [PMID: 34935162 DOI: 10.1111/imr.13056] [Reference Citation Analysis]
2 Mullican SE, Rangwala SM. Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond. Trends in Endocrinology & Metabolism 2018;29:560-70. [DOI: 10.1016/j.tem.2018.05.002] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 13.0] [Reference Citation Analysis]
3 Wang Y, Jiang T, Jiang M, Gu S. Appraising growth differentiation factor 15 as a promising biomarker in digestive system tumors: a meta-analysis. BMC Cancer 2019;19:177. [PMID: 30808336 DOI: 10.1186/s12885-019-5385-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 Lu J, Lu S, Li J, Yu Q, Liu L, Li Q. MiR-629-5p promotes colorectal cancer progression through targetting CXXC finger protein 4. Biosci Rep 2018;38:BSR20180613. [PMID: 30042169 DOI: 10.1042/BSR20180613] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Xu W, Zhou B, Wu J, Jiang P, Chen H, Yan F. Circular RNA hsa-circ-0007766 modulates the progression of Gastric Carcinoma via miR-1233-3p/GDF15 axis. Int J Med Sci 2020;17:1569-83. [PMID: 32669960 DOI: 10.7150/ijms.46261] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Buchholz K, Antosik P, Grzanka D, Gagat M, Smolińska M, Grzanka A, Gzil A, Kasperska A, Klimaszewska-Wiśniewska A. Expression of the Body-Weight Signaling Players: GDF15, GFRAL and RET and their clinical relevance in Gastric Cancer. J Cancer 2021;12:4698-709. [PMID: 34149933 DOI: 10.7150/jca.55511] [Reference Citation Analysis]
7 Siddiqui JA, Pothuraju R, Khan P, Sharma G, Muniyan S, Seshacharyulu P, Jain M, Nasser MW, Batra SK. Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia. Cytokine Growth Factor Rev 2021:S1359-6101(21)00081-2. [PMID: 34836750 DOI: 10.1016/j.cytogfr.2021.11.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Wischhusen J, Melero I, Fridman WH. Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint.Front Immunol. 2020;11:951. [PMID: 32508832 DOI: 10.3389/fimmu.2020.00951] [Cited by in Crossref: 30] [Cited by in F6Publishing: 37] [Article Influence: 15.0] [Reference Citation Analysis]
9 Li P, Ge D, Li P, Hu F, Chu J, Chen X, Song W, Wang A, Tian G, Gu X. CXXC finger protein 4 inhibits the CDK18-ERK1/2 axis to suppress the immune escape of gastric cancer cells with involvement of ELK1/MIR100HG pathway. J Cell Mol Med 2020;24:10151-65. [PMID: 32715641 DOI: 10.1111/jcmm.15625] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Assadi A, Zahabi A, Hart RA. GDF15, an update of the physiological and pathological roles it plays: a review. Pflugers Arch 2020;472:1535-46. [PMID: 32936319 DOI: 10.1007/s00424-020-02459-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Modi A, Dwivedi S, Roy D, Khokhar M, Purohit P, Vishnoi J, Pareek P, Sharma S, Sharma P, Misra S. Growth differentiation factor 15 and its role in carcinogenesis: an update. Growth Factors 2019;37:190-207. [DOI: 10.1080/08977194.2019.1685988] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
12 Rochette L, Méloux A, Zeller M, Cottin Y, Vergely C. Functional roles of GDF15 in modulating microenvironment to promote carcinogenesis. Biochim Biophys Acta Mol Basis Dis 2020;1866:165798. [PMID: 32304740 DOI: 10.1016/j.bbadis.2020.165798] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Byun HJ, Yoon JH, Lee SK. LUCAT1 Epigenetically Downregulates the Tumor Suppressor Genes CXXC4 and SFRP2 in Gastric Cancer. Yonsei Med J 2020;61:923-34. [PMID: 33107235 DOI: 10.3349/ymj.2020.61.11.923] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Fu Y, Wang Z, Luo C, Wang Y, Wang Y, Zhong X, Zheng H. Downregulation of CXXC Finger Protein 4 Leads to a Tamoxifen-resistant Phenotype in Breast Cancer Cells Through Activation of the Wnt/β-catenin Pathway. Transl Oncol 2020;13:423-40. [PMID: 31911277 DOI: 10.1016/j.tranon.2019.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Liu K, Min J. Structural Basis for the Recognition of Non-methylated DNA by the CXXC Domain. Journal of Molecular Biology 2020;432:1674-86. [DOI: 10.1016/j.jmb.2019.09.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]